Insmed (INSM) Treasury Shares (2011 - 2026)

Insmed (INSM) posted quarterly Treasury Shares of $92219.0 for Q1 2026, down 97.63% quarter-over-quarter from $3.9 million in Q4 2025.

Insmed (INSM) Treasury Shares (2011 - 2026) Analysis & Trends

Insmed's Treasury Shares history runs 16 years deep, the most recent figure standing at $92219.0 for Q1 2026.

In Q1 2026, Treasury Shares changed N/A year-over-year to $92219.0; the TTM figure through Mar 2026 stood at $92219.0 (changed N/A YoY), while the FY2025 annual figure was $3.9 million, up 17.13% from the prior year.
Treasury Shares for Q1 2026 stood at $92219.0, down from $3.9 million in the prior quarter.
The five-year high for Treasury Shares was $3.9 million in Q4 2025, with the low at $92219.0 in Q1 2026.
The 5-year median for Treasury Shares is $266550.0 (2023), against an average of $1.3 million.
The sharpest annual moves came in 2023 and 2024: Treasury Shares surged 80.95% in 2023, then fell 0.25% in 2024.
Insmed's Treasury Shares stood at $1.5 million in 2022, then surged by 80.95% to $2.8 million in 2023, then increased by 20.73% to $3.3 million in 2024, then advanced by 17.13% to $3.9 million in 2025, then sank by 97.63% to $92219.0 in 2026.
Business Quant data shows INSM's Treasury Shares at $92219.0 in Q1 2026, $3.9 million in Q4 2025, and $3.3 million in Q4 2024.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Treasury Shares (Qtr)
1	Vertex Pharmaceuticals	128.13 Bn	120.28 Bn	2.84 Bn	-
2	Regeneron Pharmaceuticals	112.33 Bn	104.33 Bn	3.93 Bn	36.40 Mn
3	Argenx Se	53.24 Bn	48.05 Bn	1.41 Bn	-
4	Revolution Medicines	43.64 Bn	43.64 Bn	-	5.08 Mn
5	BeOne Medicines	39.27 Bn	34.17 Bn	1.53 Bn	-
6	MindWalk Holdings	35.32 Bn	35.31 Bn	1.82 Bn	-
7	Royalty Pharma	33.72 Bn	35.84 Bn	-	2.72 Mn
8	Alnylam Pharmaceuticals	30.58 Bn	27.27 Bn	992.69 Mn	-
9	Insmed	27.01 Bn	25.85 Bn	358.27 Mn	92,219.00
10	Roivant Sciences	26.16 Bn	26.85 Bn	1.16 Mn	48.19 Mn

Download Data